ArticleRespiratory research2020

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.

Fernando J Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.